Ampyrone: Difference between revisions
No edit summary |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 7: | Line 7: | ||
| mass=203.241 | | mass=203.241 | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
Line 18: | Line 18: | ||
<br style="clear: both;" /> | <br style="clear: both;" /> | ||
{{Analgesics}} | {{Analgesics}} | ||
[[Category:Pyrazolones]] | [[Category:Pyrazolones]] |
Revision as of 22:07, 8 August 2012
WikiDoc Resources for Ampyrone |
Articles |
---|
Most recent articles on Ampyrone |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Ampyrone at Clinical Trials.gov Clinical Trials on Ampyrone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Ampyrone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Ampyrone Risk calculators and risk factors for Ampyrone
|
Healthcare Provider Resources |
Causes & Risk Factors for Ampyrone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Ampyrone is a metabolite of aminopyrine with analgesic, anti-inflammatory, and antipyretic properties. Due to the risk of agranulocytosis its use as a drug is discouraged. Instead it is used as a reagent for biochemical reactions producing peroxides or phenols. Ampyrone stimulates liver microsomes and is also used to measure extracellular water.
External links